LOUISVILLE, Ky.--(BUSINESS WIRE)--Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that it has signed an exclusive license to develop and market 3PO and its related compounds, discovered by scientists at the University of Louisville’s James Graham Brown Cancer Center (Brown Cancer Center).
